Boston Scientific ROA 2006-2019 | BSX

Current and historical return on assets (ROA) values for Boston Scientific (BSX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Boston Scientific ROA for the three months ending June 30, 2019 was 9.28%.
Boston Scientific ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-06-30 $1.40B $24.31B 6.24%
2019-03-31 $1.80B $23.80B 8.48%
2018-12-31 $1.67B $21.00B 8.33%
2018-09-30 $0.67B $20.38B 3.43%
2018-06-30 $0.52B $19.62B 2.72%
2018-03-31 $0.11B $19.20B 0.60%
2017-12-31 $0.10B $19.04B 0.56%
2017-09-30 $0.84B $18.64B 4.62%
2017-06-30 $0.79B $18.38B 4.37%
2017-03-31 $0.44B $17.94B 2.43%
2016-12-31 $0.35B $18.10B 1.95%
2016-09-30 $0.08B $17.70B 0.45%
2016-06-30 $-0.35B $17.84B -1.92%
2016-03-31 $-0.04B $17.72B -0.20%
2015-12-31 $-0.24B $18.13B -1.37%
2015-09-30 $-0.40B $18.22B -2.30%
2015-06-30 $-0.16B $17.12B -0.92%
2015-03-31 $-0.25B $16.47B -1.52%
2014-12-31 $-0.12B $17.02B -0.72%
2014-09-30 $0.29B $16.72B 1.74%
2014-06-30 $0.24B $16.48B 1.45%
2014-03-31 $0.37B $16.34B 2.19%
2013-12-31 $-0.12B $16.57B -0.72%
2013-09-30 $-0.17B $16.92B -0.99%
2013-06-30 $-0.83B $17.00B -4.88%
2013-03-31 $-4.54B $16.76B -26.43%
2012-12-31 $-4.07B $17.15B -22.27%
2012-09-30 $-4.02B $16.90B -20.84%
2012-06-30 $-3.22B $17.82B -15.73%
2012-03-31 $0.51B $21.19B 2.38%
2011-12-31 $0.44B $21.29B 2.04%
2011-09-30 $0.57B $21.50B 2.61%
2011-06-30 $0.62B $21.56B 2.80%
2011-03-31 $0.57B $22.07B 2.54%
2010-12-31 $-1.07B $22.13B -4.71%
2010-09-30 $-2.38B $22.49B -10.17%
2010-06-30 $-2.66B $23.02B -10.94%
2010-03-31 $-2.60B $22.85B -10.36%
2009-12-31 $-1.03B $25.18B -3.95%
2009-09-30 $-2.33B $26.23B -8.82%
2009-06-30 $-2.31B $26.19B -8.46%
2009-03-31 $-2.37B $26.11B -8.40%
2008-12-31 $-2.04B $27.14B -6.95%
2008-09-30 $-0.11B $29.83B -0.37%
2008-06-30 $-0.31B $29.90B -1.01%
2008-03-31 $-0.29B $30.35B -0.94%
2007-12-31 $-0.50B $31.20B -1.59%
2007-09-30 $0.24B $31.33B 0.77%
2007-06-30 $0.59B $31.27B 1.90%
2007-03-31 $-3.79B $31.07B -12.29%
2006-12-31 $-3.58B $30.88B -14.12%
2006-09-30 $-3.52B $30.75B -17.90%
2006-06-30 $-3.87B $30.61B -27.61%
2006-03-31 $0.60B $9.11B 7.20%
2005-12-31 $0.63B $8.20B 7.81%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $53.170B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.598B 26.57
Medtronic (MDT) Ireland $145.585B 20.43
Stryker (SYK) United States $80.642B 27.89
Baxter (BAX) United States $44.852B 27.20
EssilorLuxottica Societe Anonyme (ESLOY) France $32.725B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.438B 18.20
Coloplast (CLPBY) Denmark $25.747B 41.10
Lonza Group Ag (LZAGY) Switzerland $25.481B 0.00
Terumo (TRUMY) Japan $24.495B 30.57
Smith & Nephew SNATS (SNN) United Kingdom $20.928B 0.00
ResMed (RMD) United States $18.924B 36.06
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.234B 54.86
Insulet (PODD) United States $9.431B 558.86
Perrigo (PRGO) Ireland $7.400B 13.63
Canopy Growth (CGC) Canada $7.222B 0.00
Hill-Rom Holdings (HRC) United States $6.830B 20.36
Haemonetics (HAE) United States $6.455B 48.71
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $4.002B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.680B 0.00
Neogen (NEOG) United States $3.490B 58.40
NuVasive (NUVA) United States $3.398B 27.09
ICU Medical (ICUI) United States $3.237B 21.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.634B 0.00
Quidel (QDEL) United States $2.510B 24.93
Agios Pharmaceuticals (AGIO) United States $1.982B 0.00
National Vision Holdings (EYE) United States $1.877B 40.51
Cardiovascular Systems (CSII) United States $1.670B 0.00
Aphria (APHA) $1.242B 0.00
VAREX IMAGING (VREX) United States $1.124B 25.90
AtriCure (ATRC) United States $1.059B 0.00
Phibro Animal Health (PAHC) United States $0.867B 14.10
Eagle Pharmaceuticals (EGRX) United States $0.854B 21.78
NanoString Technologies (NSTG) United States $0.787B 0.00
Omeros (OMER) United States $0.759B 0.00
Lantheus Holdings (LNTH) United States $0.734B 19.29
PetIQ (PETQ) United States $0.725B 17.13
LeMaitre Vascular (LMAT) United States $0.689B 40.82
Cerus (CERS) United States $0.624B 0.00
Surmodics (SRDX) United States $0.621B 118.00
MacroGenics (MGNX) United States $0.560B 0.00
Quanterix (QTRX) United States $0.548B 0.00
TG Therapeutics (TGTX) United States $0.530B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.23
Owens & Minor (OMI) United States $0.459B 13.76
Meridian Bioscience (VIVO) United States $0.427B 13.32
Utah Medical Products (UTMD) United States $0.354B 25.91
Zynex (ZYXI) United States $0.346B 36.76
BioLife Solutions (BLFS) United States $0.339B 104.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.327B 0.00
Bovie Medical (APYX) United States $0.234B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Vapotherm (VAPO) United States $0.177B 0.00
Repro-Med Systems (REPR) United States $0.158B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.147B 0.00
Female Health (VERU) United States $0.138B 0.00
Fonar (FONR) United States $0.133B 9.32
InfuSystems Holdings (INFU) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.088B 0.00
Nephros (NEPH) United States $0.087B 0.00
United-Guardian (UG) United States $0.084B 19.82
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.039B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00